|
1
|
Dubey AK, Gupta U and Jain S: Epidemiology
of lung cancer, approaches for its prediction: A systematic review
and analysis. Chin J Cancer. 35:712016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Colombet M, Soerjomataram I,
Parkin DM, Piñeros M, Znaor A and Bray F: Cancer statistics for the
year 2020: An overview. Int J Cancer. 149:778–789. 2021. View Article : Google Scholar
|
|
3
|
Jurisic V, Obradovic J, Nikolic N, Javorac
J, Perin B and Milasin J: Analyses of P16INK4a gene
promoter methylation relative to molecular, demographic, clinical
parameters characteristics in non-small cell lung cancer patients:
A pilot study. Mol Biol Rep. 50:971–979. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Petrović M, Bukumirić Z, Zdravković V,
Mitrović S, Atkinson HD and Jurišić V: The prognostic significance
of the circulating neuroendocrine markers chromogranin A,
pro-gastrin-releasing peptide, and neuron-specific enolase in
patients with small-cell lung cancer. Med Oncol. 31:8232014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Socinski MA and Pennell NA: Best practices
in treatment selection for patients with advanced NSCLC. Cancer
Control. 23 (4 Suppl):S2–S4. 2016. View Article : Google Scholar
|
|
6
|
Zappa C and Mousa SA: Non-small cell lung
cancer: Current treatment and future advances. Transl Lung Cancer
Res. 5:288–300. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pilkington G, Boland A, Brown T, Oyee J,
Bagust A and Dickson R: A systematic review of the clinical
effectiveness of first-line chemotherapy for adult patients with
locally advanced or metastatic non-small cell lung cancer. Thorax.
70:359–367. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Luo YH, Wang C, Xu WT, Zhang Y, Zhang T,
Xue H, Li YN, Fu ZR, Wang Y and Jin CH: 18β-Glycyrrhetinic acid Has
Anti-cancer effects via inducing apoptosis and G2/M cell cycle
arrest, and inhibiting migration of A549 lung cancer cells. Onco
Targets Ther. 14:5131–5144. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Proneth B and Conrad M: Ferroptosis and
necroinflammation, a yet poorly explored link. Cell Death Differ.
26:14–24. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Galluzzi L, Vitale I, Aaronson SA, Abrams
JM, Adam D, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews
DW, et al: Molecular mechanisms of cell death: Recommendations of
the Nomenclature Committee on Cell Death 2018. Cell Death Differ.
25:486–541. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hassannia B, Vandenabeele P and Berghe TV:
Targeting ferroptosis to iron out cancer. Cancer Cell. 35:830–849.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liang C, Zhang X, Yang M and Dong X:
Recent progress in ferroptosis inducers for cancer therapy. Adv
Mater. 31:19041972019. View Article : Google Scholar
|
|
13
|
Bebber CM, Müller F, Clemente LP, Weber J
and Karstedt SV: Ferroptosis in cancer cell biology. Cancers.
12:1642020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lewerenz J, Hewett SJ, Huang Y, Lambros M,
Gout PW, Kalivas PW, Massie A, Smolders I, Methner A, Pergande M,
et al: The Cystine/glutamate Antiporter system x(c)(−) in health,
disease: From molecular mechanisms to novel therapeutic
opportunities. Antioxid Redox Signal. 18:522–555. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bridges RJ, Natale NR and Patel SA: System
xc− Cystine/glutamate antiporter: An update on molecular
pharmacology and roles within the CNS. Br J Pharmacol. 165:20–34.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta
R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS,
et al: Ferroptosis: An Iron-dependent form of nonapoptotic cell
death. Cell. 149:1060–1072. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang WS, SriRamaratnam R, Welsch ME,
Shimada K, Skouta R, Viswanathan VS, Cheah JH, Clemons PA, Shamji
AF, Clish CB, et al: Regulation of ferroptotic cancer cell death by
GPX4. Cell. 156:317–331. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ursini F, Maiorino M, Valente M, Ferri L
and Gregolin C: Purification from pig liver of a protein which
protects liposomes and biomembranes from peroxidative degradation
and exhibits glutathione peroxidase activity on phosphatidylcholine
hydroperoxides. Biochim Biophys Acta. 710:197–211. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ji X, Qian J, Rahman SMJ, Siska PJ, Zou Y,
Harris BK, Hoeksema MD, Trenary IA, Heidi C, Eisenberg R, et al:
xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small
cell lung cancer progression. Oncogene. 37:5007–5019. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Koppula P, Zhang Y, Zhuang L and Gan B:
Amino acid transporter SLC7A11/xCT at the crossroads of regulating
redox homeostasis and nutrient dependency of cancer. Cancer Commun
(Lond). 38:122018.PubMed/NCBI
|
|
21
|
Sun B, Xiao J, Sun XB and Wu Y:
Notoginsenoside R1 attenuates cardiac dysfunction in endotoxemic
mice: An insight into oestrogen receptor activation and PI3K/Akt
signalling. British J Pharmacology. 168:1758–1770. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Guo Q, Li P, Wang Z, Cheng Y, Wu H, Yang
B, Du S and Lu Y: Brain distribution pharmacokinetics and
integrated pharmacokinetics of Panax Notoginsenoside R1,
Ginsenosides Rg1, Rb1, Re and Rd in rats after intranasal
administration of Panax Notoginseng Saponins assessed by
UPLC/MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci.
969:264–271. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lee CY, Hsieh SL, Hsieh S, Tsai CC, Hsieh
LC, Kuo YH and Wu CC: Inhibition of human colorectal cancer
metastasis by notoginsenoside R1, an important compound from
Panax notoginseng. Oncol Rep. 37:399–407. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang W, Shu H, Fang L, Tang N, Li Y, Guo
B and Meng F: Cancer inhibition mechanism of lung cancer mouse
model based on dye trace method. Saudi J Biol Sci. 27:1155–1162.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hsieh SL, Hsieh S, Kuo YH, Wang JJ, Wang
JC and Wu CC: Effects of Panax notoginseng on the metastasis
of human colorectal cancer cells. Am J Chin Med. 44:851–870. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhou Y, Zhang X, Wang X, Li Y, Liu Z,
Zhang J, Chen L, Xu Y, Yang Y and Wang Z: Ferroptosis in cancer:
From molecular mechanisms to therapeutic applications. Nat Rev
Cancer. 24:1–15. 2024.PubMed/NCBI
|
|
27
|
Xie Y, Hou W, Song X, Yu Y, Huang J, Sun
X, Kang R and Tang D: Ferroptosis: Process and function. Cell Death
Differ. 23:369–79. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Muckenthaler MU, Galy B and Hentze MW:
Systemic iron homeostasis and the iron-responsive
element/iron-regulatory protein (IRE/IRP) regulatory network. Annu
Rev Nutr. 28:197–213. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang WS and Stockwell BR: Synthetic lethal
screening identifies compounds activating iron-dependent,
nonapoptotic cell death in oncogenic-RAS-harboring cancer cells.
Chem Biol. 15:234–245. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ganz T and Nemeth E: Hepcidin and iron
homeostasis. Biochim Biophys Acta. 1823:1434–1443. 2012. View Article : Google Scholar : PubMed/NCBI
|
